Cyclodiode vs micropulse transscleral laser treatment

Monica Kelada,Eduardo M. Normando,Francesca M. Cordeiro,Laura Crawley,Faisal Ahmed,Sally Ameen,Niten Vig,Philip Bloom
DOI: https://doi.org/10.1038/s41433-024-02929-1
IF: 4.4563
2024-01-31
Eye
Abstract:Continuous-wave transscleral cyclophotocoagulation (CW-TSCP) is usually reserved for advanced/refractory glaucoma. Micropulse transscleral laser therapy (MPTLT) utilises short energy pulses separated by ' off '-periods. MPTLT is postulated to have fewer complications, but its relative efficacy is not known. The National Institute for Health and Care Excellence (NICE) has deemed the evidence supporting MPTLT use of inadequate quality, limiting its use to research. This study aims to evaluate MPTLT efficacy and safety compared to CW-TSCP.
ophthalmology
What problem does this paper attempt to address?